Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP

被引:1
作者
Ugocsai, K
Varga, A
Molnár, P
Antus, S
Molnár, J
机构
[1] Univ Szeged, Fac Gen Med, Dept Med & Microbiol Immunobiol, H-6720 Szeged, Hungary
[2] Humboldt Univ, Dept Mol Parasitol, Berlin, Germany
[3] Univ Pecs, Dept Biochem, Pecs, Hungary
[4] Univ Pecs, Dept Med Chem, Pecs, Hungary
[5] Univ Debrecen, Dept Organ Chem, H-4012 Debrecen, Hungary
来源
IN VIVO | 2005年 / 19卷 / 02期
关键词
colon cancer cell lines; carotenoids; flavonoids; multidrug resistance; MDR1/LRP; apoptosis;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The effects of various flavonoids and carotenoids on Rhodamine 123 accumulation in multidrug-resistant Colo 320 human colon cancer cells expressing MDR1/LRP were studied. The Colo 205 cell line was used as a drug-sensitive control. Rotenon, Catechin, Neohesperidin, Naringin, Robinin, Phloridzin, Robinetin, Dihydrobinetin, Dihydrofisetin, Kampferol, Dihidroquercetin, Sakuranin and Sakuranetin were tested on Colo 320 cells: only Rotenon was found to be effective as regards multidrug resistance (MDR) reversal, while a majority of the flavonoids, such as Catechin, Neohesperidin, Naringin, Robinin, Phloridzin, Dihydrobinetin and Sakuranetin, had only marginal effects on Rhodamine 123 accumulation. The tested carotenoids (P-Cryptoxanthin, Luteoxanthin, Anteroxanthin, Violeoxanthin, Apple peel fetoxanthin, Lutein, Violaxanthin and Neoxanthin) were able to increase Rhodamine 123 accumulation in Colo 320 cells. Verapamil was applied as a resistance-modifying positive control. The levels of apoptosis induction in drug-resistant and sensitive cell lines were also compared. The results indicated that the tested flavonoids were weak apoptosis inducers on MDR and parent cells, without significant differences. A majority of the carotenoids induced only early apoptosis, but apoptosis and cell death were not induced in MDR colon cancer cells.
引用
收藏
页码:433 / 438
页数:6
相关论文
共 33 条
[1]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[2]  
Aszalos A, 1998, ANTICANCER RES, V18, P2937
[3]   RETINOIDS IN CANCER PREVENTION AND THERAPY [J].
BOLLAG, W ;
HOLDENER, EE .
ANNALS OF ONCOLOGY, 1992, 3 (07) :513-526
[4]   Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance [J].
Boumendjel, A ;
Di Pietro, A ;
Dumontet, C ;
Barron, D .
MEDICINAL RESEARCH REVIEWS, 2002, 22 (05) :512-529
[5]  
DALTON WS, 1999, JNCI-J NATL CANCER I, V92, P1295
[6]   The human ATP-binding cassette (ABC) transporter superfamily [J].
Dean, M ;
Rzhetsky, A ;
Allikmets, R .
GENOME RESEARCH, 2001, 11 (07) :1156-1166
[7]  
Ferry DR, 1996, CLIN CANCER RES, V2, P659
[8]   Flavonoid-related modulators of multidrug resistance:: Synthesis, pharmacological activity, and structure-activity relationships [J].
Ferté, J ;
Kühnel, JM ;
Chapuis, G ;
Rolland, Y ;
Lewin, G ;
Schwaller, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (03) :478-489
[9]  
FORD JM, 1990, PHARMACOL REV, V42, P155
[10]  
FORD JM, 1989, MOL PHARMACOL, V35, P105